Study Examines Barriers to Human Papillomavirus Vaccination Among Teens

Article

Barriers to human papillomavirus (HPV) vaccination among adolescents in the U.S. range from financial concerns and parental attitudes to social influences and concerns about the vaccinations effect on sexual behavior, according to a review of the available medical literature published by JAMA Pediatrics.
 
HPV vaccine coverage among teenagers has increased since the vaccine was licensed in 2006 but it still remains low compared with other recommended vaccinations. Most HPV infections will clear on their own, but persistent infections can progress to precancers or cancers, including cervical, vulvar, vaginal, penile and anal cancer, as well as cancers of the mouth and throat. Vaccination is recommended for both girls and boys, based on age requirements for the specific vaccines, according to the study background.
 
Dawn M. Holman, MPH, of the Centers for Disease Control and Prevention (CDC), and colleagues conducted a review of the literature on barriers to HPV vaccination. Their findings summarize 55 relevant articles, which include data collected in 2009 or later:
- Healthcare professionals cited financial concerns and parental attitudes and concerns as barriers to providing the vaccine to patients.
- Parents often reported barriers that included needing more information before vaccinating their children, as well as concerns about the vaccines effect on sexual behavior, the low perceived risk of HPV infection, social influences, irregular preventive care and vaccine costs.
- Some parents of boys reported a perceived lack of benefit for vaccinating their sons.
- Recommendations from health care professionals were consistently reported by parents as one of the most important factors in their decision to vaccinate their children.
 
Continued efforts are needed to ensure that healthcare professionals and parents understand the importance of vaccinating adolescents before they become sexually active. Healthcare professionals may benefit from guidance on communicating HPV recommendations to patients and parents, the study concludes.

Reference: JAMA Pediatr. Published online Nov. 25, 2013. doi:10.1001/jamapediatrics.2013.2752.

Related Videos
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Related Content